Rejuvenation biotech - progress and potential, with Karl Pfleger

Our guest in this episode is Karl Pfleger. Karl is an angel investor in rejuvenation biotech startups, and is also known for creating and maintaining the website Aging Biotech Info. That website describes itself as “Structured info about aging and longevity”, and has the declared mission statement, “Everything important in the field (outside of academia), organized.”Previously, Karl worked at Google from 2002 to 2013, as a research scientist and data analyst, applying AI and machine learning at scale. He has a BSE in Computer Science from Princeton, and a PhD in Computer Science and AI from Stanford.Previous London Futurists Podcast episodes mentioned in this conversation:Ep 74: The Longevity Singularity, with Daniel IvesEp 45: Generative AI drug discovery breakthrough, with Alex ZhavoronkovEp 12: Pioneering AI drug development, with Alex ZhavoronkovOther selected follow-ups:AgingBiotech.InfoLifespan.io rejuvenation roadmapAgingDB listStealth BiotherapeuticsNewLimitJuvenityJuvena TherapeuticsImmunisPartnership between Calico and AbbVieHevolutionUnity BiotechnologyHere's Why resTORbio Fell Over 83% TodayA4LI Responds to NIH Reform ProposalGreat Desire for Extended Life and Health amongst the American Public - a paper by Karl Pfleger. Kristen Fortney, Joe Betts-LaCroix and others, LEV achieved for young people before it is achieved for old peopleLongevity Biotech FellowshipForesight InstituteLongevity GlobalVitalism.IOMusic: Spike Protein, by Koi Discovery, available under CC0 1.0 Public Domain DeclarationC-Suite PerspectivesElevate how you lead with insight from today’s most influential executives.Listen on: Apple Podcasts   Spotify